# Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission

> **NCT02365480** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 18 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Berberine Chloride
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Placebo Administration

## Key facts

- **NCT ID:** NCT02365480
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-16
- **Primary completion:** 2018-02-16
- **Final completion:** 2019-12-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365480, "Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02365480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*